by Hebrew University of Jerusalem The opioid crisis continues to pose a grave public health concern, with synthetic opioids such as fentanyl posing a major risk for development of addiction and death due to overdose. A recent study by the research group led by Prof. Ami Citri at the Hebrew University of Jerusalem’s Edmond and Lily...
by Benjamin Boettner, Harvard University This cryoEM image shows an ECM-mimicking hydrogel with room for T cells to pass through and attach to the specifically engineered collagen matrix. Credit: Wyss Institute at Harvard University The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient,...
by European Society of Human Reproduction and Embryology More than three months after suffering from mild COVID infection, men have lower sperm concentrations and fewer sperm that are able to swim, according to new findings presented at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). Professor Rocio Núñez-Calonge, scientific advisor...
June 25, 2023 10:39 PM EDTUpdated 05:32 AM R&DNovo Nordisk’s oral semaglutide on par with injectable version in weight loss and safetyKatherine LewinNews ReporterAn oral version of Novo Nordisk’s semaglutide helped patients taking the highest dose lose 15% of their body weight, the company reported in a new update. It’s on par with Novo’s Wegovy,...
By UNIVERSITY OF HELSINKI JUNE 26, 2023 Dementia, a prevalent and distressing neurodegenerative disorder, exerts its grip on countless individuals across the globe. This condition manifests through a progressive decline in cognitive functions, including memory impairment and the inability to carry out routine activities. As the disease advances, individuals grappling with dementia encounter substantial challenges in communication,...
by Eric W. Dolan June 26, 2023 in Mental Health [Subscribe to PsyPost Premium to enjoy an ad-free experience! Click here to sign up.] New research suggests that drugs used to treat insulin resistance could potentially help in treating neurodegenerative disorders like Parkinson’s disease. The study found that semaglutide, a compound found in medications like...
by Agency for Science, Technology and Research (A*STAR), Singapore A 12-month longitudinal systemic cytokine analysis of COVID-19 patients reveals a cluster of patients with persisting elevations of proinflammatory cytokines. Longitudinal plasma samples were collected across 5 time points up to 12 months post-illness onset from 78 COVID-19 patients. Concentrations of 45 immune mediators were quantified using a 45-plex...
by University of California – San Diego Credit: Pixabay/CC0 Public Domain Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis. The results, published in the June 24, 2023, online edition of The New England Journal of Medicine, found...
by RIKEN A schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mice that had human lung cancer implants. The TAT targets acrolein, which is abundant in cancer cells, but not in healthy cells. After reacting with...
by NYU Langone Health Illustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of Health Recurrent bouts of systemic lupus erythematosus, marked by the body’s immune system attack of its own tissues, closely tracked with measureable upticks in growth in the gut of a certain species of bacteria. New research from NYU...
